Cancer3.AI › Latest Research

Latest Research

All publications from the Cancer3.AI database, newest first.

ICD: C32 WHO Vol. 9 Head & Neck
2026-04-06

A Health Systems Analysis of Global Head and Neck Cancer Outcomes.

Dee EC, et al

A new study published in The Laryngoscope examined how national health system characteristics influence outcomes for patients with head and neck cancers (HNC), including cancers of the oral cavity, throat, larynx, and salivary glands, across 185 countries. Researchers used data from the GLOBOCAN 2022 database to calculate the mortality-to-incidence ratio (MIR) — a measure of how lethal a cancer is relative to how often it is diagnosed — and tested its association with eleven health system indicators. The analysis found that all eleven indicators, spanning health financing, workforce density, and socioeconomic development, were significantly linked to HNC outcomes, but two factors stood out in the multivariable model: higher Universal Health Coverage (UHC) index scores and greater GDP per capita were independently associated with better survival outcomes, together explaining 70% of the variation in MIR across countries. These findings confirm that low- and middle-income countries bear a disproportionate burden of HNC mortality, not simply because of higher disease rates, but because weaker health systems limit access to timely diagnosis and treatment. For policymakers and global health advocates, the study provides clear evidence that investing in universal health coverage and economic development are among the most impactful strategies for reducing the global head and neck cancer burden.

The Laryngoscope

Source →
ICD: C32 WHO Vol. 9 Head & Neck
2026-04-06

Current status of imaging in residual or recurrent squamous cell carcinoma of the head and neck.

Kashiwagi N, et al

A new review article published in Auris, Nasus, Larynx examines the current role of radiological imaging techniques in monitoring patients with head and neck squamous cell carcinoma (HNSCC) after treatment. The authors evaluated multiple imaging modalities, finding that contrast-enhanced CT remains the primary tool for detecting locoregional recurrence, while MRI is preferred when tumors are located near the skull base due to its superior ability to detect bone invasion and nerve involvement. Diffusion-weighted MRI showed strong diagnostic performance in distinguishing residual or recurrent cancer from normal post-treatment tissue changes. FDG-PET/CT demonstrated sensitivity equal to or greater than CT and MRI for detecting both local and distant recurrence, but its high cost means it is best used at strategic timepoints, such as three to six months after completing definitive treatment or before salvage surgery. The Neck Imaging Reporting and Data System (NI-RADS) was highlighted as an important tool for standardizing how recurrence is reported and interpreted across institutions. This comprehensive overview helps clinicians select the most appropriate imaging strategy for each patient, potentially improving early detection of recurrence and guiding timely treatment decisions.

Auris, nasus, larynx

Source →
ICD: C48 WHO Vol. 1 Digestive System
2026-04-05

Income, treatment patterns and outcome in patients with stage IV colorectal cancer.

Galanos LJ, et al

A large Dutch population-based study investigated whether income level affects how patients with stage IV colorectal cancer — cancer that has spread beyond the bowel — are diagnosed, treated, and how long they survive. Drawing on data from the Netherlands Cancer Registry covering 24,666 patients diagnosed between 2015 and 2023, researchers found that higher-income patients were more often detected through cancer screening programs and significantly more likely to receive curative-intent treatments for liver and peritoneal metastases. Systemic therapy such as chemotherapy was administered to 56% of higher-income patients compared to only 42% of those with the lowest incomes, a disparity that persisted even after adjusting for clinical and patient factors. These treatment differences translated into a meaningful survival gap, with three-year relative survival of 26% in the highest income group versus 21% in the lowest, and lower-income patients carrying a statistically significantly elevated risk of death. The findings expose a troubling socioeconomic inequality in access to cancer care that clinicians, health systems, and policymakers urgently need to address to ensure equitable oncological treatment for all patients.

European journal of cancer (Oxford, England : 1990)

Source →
ICD: C56-C57 WHO Vol. 4 Female Reproductive System
2026-04-05

Clinicopathological and molecular characteristics of small cell carcinoma of the ovary, hypercalcemic type: three case reports.

Jiang W, et al

Researchers report three cases of small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), an exceptionally rare and aggressive malignancy that predominantly affects young women and is associated with elevated blood calcium levels. The study examined the clinicopathological and molecular characteristics of these cases, focusing on features such as tumor morphology, immunohistochemical profiles, and genetic alterations, particularly mutations in the SMARCA4 gene, which is considered a hallmark of this disease. Findings from the three cases contributed to a better understanding of this poorly characterized cancer's behavior, diagnostic challenges, and potential molecular targets. Because SCCOHT carries a dismal prognosis and is frequently misdiagnosed due to its rarity, detailed case reports such as this one are valuable for improving clinical recognition and guiding treatment decisions. This work underscores the importance of molecular testing in young patients presenting with aggressive ovarian masses and hypercalcemia, and highlights the need for continued research into targeted therapies for this devastating disease.

Discover oncology

Source →
ICD: C68 WHO Vol. 8 Urinary Tract
2026-04-05

Immediate Repair for Laceration of the Tunica Albuginea of the Corpora Cavernosa and Penile Urethral Injury Caused by Blunt Trauma to the Flaccid Penis: A Case Report.

Fujimura R, et al

Researchers report a rare case of a 31-year-old man who suffered a serious penile injury during a basketball game, despite the penis being in a flaccid state at the time of impact. Blunt trauma caused a laceration of the tunica albuginea — the fibrous sheath surrounding the erectile tissue — as well as partial tearing of the penile urethra, leading to blood in the urine and inability to urinate. Computed tomography imaging was instrumental in diagnosing the injury before surgery, where both the tunica albuginea and urethra were successfully repaired and a temporary suprapubic catheter was placed to allow healing. An unexpected complication arose when urethral leakage was detected on postoperative day 24 despite initial clear imaging, requiring the catheter to be maintained for three months. Ultimately, the patient made a full recovery with no urethral narrowing or stricture, demonstrating that prompt surgical intervention is effective even in these atypical blunt-force penile injuries. This case highlights that clinicians should consider serious structural penile damage even when trauma occurs to a flaccid penis, and that delayed urethral leakage remains a potential complication requiring vigilant follow-up.

IJU case reports

Source →